Animal Vaccines Market by Type and Animal Type: Global Opportunity Analysis and Industry Forecast, 2021-2030

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits to the stakeholders
1.3. Key market segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Government Regulations
3.3.1. Center for Veterinary Biologics (CVB)
3.4. Top player positioning
3.5. Porter’s five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Growth in demand for pet insurance
3.6.1.2. Increase in prevalence of animal diseases
3.6.1.3. Growth in ownership of companion animal
3.6.1.4. Rise in animal health expenditure
3.6.2. Restraints
3.6.2.1. Highly competitive meat and milk prices
3.6.2.2. Adverse impact of veterinary vaccines on human and animal health
3.6.3. Opportunities
3.6.3.1. Advancement in vaccine products
3.6.3.2. Increase in demand for hybrid animal
3.7. COVID-19 Impact Analysis on the market
3.8. mRNA animal vaccine clinical analysis
3.9. Pricing analysis

CHAPTER 4: ANIMAL VACCINES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Attenuated Vaccines
4.2.1. Key market trends, key growth factors and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Inactivated Vaccines
4.3.1. Key market trends, key growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Subunit Vaccines
4.4.1. Key market trends, key growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Toxoid Vaccines
4.5.1. Key market trends, key growth factors and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Conjugate Vaccines
4.6.1. Key market trends, key growth factors and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Recombinant Vaccines
4.7.1. Key market trends, key growth factors and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. DNA Vaccines
4.8.1. Key market trends, key growth factors and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country

CHAPTER 5: ANIMAL VACCINES MARKET, BY ANIMAL TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Companion animal
5.2.1. Market size and forecast, by type
5.2.1.1. Dogs
5.2.1.1.1. Market size and forecast
5.2.1.1.2. Market size and forecast, by disease
5.2.1.2. Cats
5.2.1.2.1. Market size and forecast
5.2.1.2.2. Market size and forecast, by disease
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Livestock Animal
5.3.1.1. Cattle
5.3.1.1.1. Market size and forecast
5.3.1.1.2. Market size and forecast, by disease
5.3.1.2. Pigs
5.3.1.2.1. Market size and forecast
5.3.1.2.2. Market size and forecast, by disease
5.3.1.3. Poultry
5.3.1.3.1. Market size and forecast
5.3.1.3.2. Market size and forecast, by disease
5.3.1.4. Sheep
5.3.1.4.1. Market size and forecast
5.3.1.4.2. Market size and forecast, by disease
5.3.1.5. Horses
5.3.1.5.1. Market size and forecast
5.3.1.5.2. Market size and forecast, by disease
5.3.1.6. Others
5.3.1.6.1. Market size and forecast
5.3.1.6.2. Market size and forecast, by disease
5.4. Aquaculture
5.4.1. Market size and forecast
5.4.2. Market size and forecast, by disease
5.4.3. Market analysis, by country

CHAPTER 6: ANIMAL VACCINES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, key growth factors and opportunities
6.2.2. Market size and forecast, by product
6.2.3. Market size and forecast, by animal type
6.2.4. Market size and forecast, by country
6.2.4.1. U. S. market size and forecast, by product
6.2.4.2. U. S. market size and forecast, by animal type
6.2.4.3. Canada market size and forecast, by product
6.2.4.4. Canada market size and forecast, by animal type
6.2.4.5. Mexico market size and forecast, by product
6.2.4.6. Mexico market size and forecast, by animal type
6.3. Europe
6.3.1. Key market trends, key growth factors and opportunities
6.3.2. Market size and forecast, by product
6.3.3. Market size and forecast, by animal type
6.3.4. Market size and forecast, by country
6.3.4.1. Germany market size and forecast, by product
6.3.4.2. Germany market size and forecast, by animal type
6.3.4.3. France market size and forecast, by product
6.3.4.4. France market size and forecast, by animal type
6.3.4.5. UK market size and forecast, by product
6.3.4.6. UK market size and forecast, by animal type
6.3.4.7. Italy market size and forecast, by product
6.3.4.8. Italy market size and forecast, by animal type
6.3.4.9. Rest of Europe market size and forecast, by product
6.3.4.10. Rest of Europe market size and forecast, by animal type
6.4. Asia-Pacific
6.4.1. Key market trends, key growth factors and opportunities
6.4.2. Market size and forecast, by product
6.4.3. Market size and forecast, by animal type
6.4.4. Market size and forecast, by country
6.4.4.1. Japan market size and forecast, by product
6.4.4.2. Japan market size and forecast, by animal type
6.4.4.3. China market size and forecast, by product
6.4.4.4. China market size and forecast, by animal type
6.4.4.5. Australia market size and forecast, by product
6.4.4.6. Australia market size and forecast, by animal type
6.4.4.7. India market size and forecast, by product
6.4.4.8. India market size and forecast, by animal type
6.4.4.9. South Korea market size and forecast, by product
6.4.4.10. South Korea market size and forecast, by animal type
6.4.4.11. Rest of Asia-Pacific market size and forecast, by product
6.4.4.12. Rest of Asia-Pacific market size and forecast, by animal type
6.5. LAMEA
6.5.1. Key market trends, key growth factors and opportunities
6.5.2. Market size and forecast, by product
6.5.3. Market size and forecast, by animal type
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by product
6.5.4.2. Brazil market size and forecast, by animal type
6.5.4.3. Saudi Arabia market size and forecast, by product
6.5.4.4. Saudi Arabia market size and forecast, by animal type
6.5.4.5. Rest of LAMEA market size and forecast, by product
6.5.4.6. Rest of LAMEA market size and forecast, by animal type

CHAPTER 7: COMPANY PROFILES
7.1. ANICON LABOR GMBH
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.2. BOEHRINGER INGELHEIM GMBH
7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Product portfolio
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. CEVA SANTÉ ANIMALE
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Product portfolio
7.3.4. Key strategic moves and developments
7.4. HYGIEIA BIOLOGICAL LABORATORIES
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. MERCK & COMPANY INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. ROMVAC COMPANY S. A.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.7. SANOFI S. A.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. VAXXINOVA GMBH
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Key strategic moves and developments
7.9. VIRBAC S. A
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. ZOETIS INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves & developmentsLIST OF TABLES
TABLE 01. NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)
TABLE 02. POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2019
TABLE 03. MRNA ANIMAL VACCINE: CLINICAL ANALYSIS
TABLE 04. NORTH AMERICA: ANIMAL VACCINES PRICES
TABLE 05. EUROPE: ANIMAL VACCINES PRICES
TABLE 06. ASIA-PACIFIC: ANIMAL VACCINES PRICES
TABLE 07. LAMEA: ANIMAL VACCINES PRICES
TABLE 08. ANIMAL VACCINES MARKET, BY PRODUCT TYPE 2020-2030, ($MILLION)
TABLE 09. ANIMAL VACCINES MARKET FOR ATTENUATED VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 10. ANIMAL VACCINES MARKET FOR INACTIVATED VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 11. ANIMAL VACCINES MARKET FOR SUBUNIT VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 12. ANIMAL VACCINES MARKET FOR TOXOID VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 13. ANIMAL VACCINES MARKET FOR CONJUGATE VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 14. ANIMAL VACCINES MARKET FOR RECOMBINANT VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 15. ANIMAL VACCINES MARKET FOR DNA VACCINES BY REGION 2020-2030, ($MILLION)
TABLE 16. ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 17. COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2030, ($MILLION)
TABLE 18. VACCINATION FOR DOGS: CORE AND NON-CORE
TABLE 19. ANIMAL VACCINES MARKET FOR DOGS, BY DISEASE, 2020-2030 ($MILLION)
TABLE 20. VACCINATION FOR CATS: CORE AND NON-CORE
TABLE 21. ANIMAL VACCINES MARKET FOR CATS, BY DISEASE, 2020-2030 ($MILLION)
TABLE 22. COMPANION ANIMAL VACCINES MARKET, BY REGION, 2020-2030, ($MILLION)
TABLE 23. LIVESTOCK ANIMAL VACCINES MARKET, BY TYPE, 2020-2030, ($MILLION)
TABLE 24. ANIMAL VACCINES MARKET FOR CATTLE, BY DISEASE, 2020-2030 ($MILLION)
TABLE 25. TOP 5 PORK CONSUMING COUNTRIES, 2020
TABLE 26. ANIMAL VACCINES MARKET FOR PIGS, BY DISEASE, 2020-2030 ($MILLION)
TABLE 27. TOP 5 POULTRY CONSUMING COUNTRIES, 2020
TABLE 28. ANIMAL VACCINES MARKET FOR POULTRY, BY DISEASE, 2020-2030 ($MILLION)
TABLE 29. TOP 5 SHEEP MEAT CONSUMING COUNTRIES, 2020
TABLE 30. ANIMAL VACCINES MARKET FOR SHEEP, BY DISEASE, 2020-2030 ($MILLION)
TABLE 31. ANIMAL VACCINES MARKET FOR HORSES, BY DISEASE, 2020-2030 ($MILLION)
TABLE 32. LIVESTOCK ANIMAL VACCINES MARKET, BY REGION, 2020-2030, ($MILLION)
TABLE 33. AQUACULTURE ANIMAL VACCINES MARKET, BY REGION, 2020-2030, ($MILLION)
TABLE 34. ANIMAL VACCINES MARKET FOR AQUACULTURE, BY DISEASE, 2020-2030 ($MILLION)
TABLE 35. ANIMAL VACCINES MARKET, BY REGION 2020-2030, ($MILLION)
TABLE 36. NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 37. NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 38. NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 39. U.S. ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 40. U.S. ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 41. CANADA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 42. CANADA ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 43. MEXICO ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 44. MEXICO VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 45. EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 46. EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 47. EUROPE ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 48. GERMANY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 49. GERMANY VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 50. FRANCE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 51. FRANCE VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 52. UK ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 53. UK VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 54. ITALY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 55. ITALY VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 56. REST OF EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 57. REST OF EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 58. ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 59. ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 60. ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 61. JAPAN ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 62. JAPAN VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 63. CHINA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 64. CHINA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 65. AUSTRALIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 66. AUSTRALIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 67. INDIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 68. INDIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 69. SOUTH KOREA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 70. SOUTH KOREA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 73. LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 74. LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 75. LAMEA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 76. BRAZIL ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 77. BRAZIL VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 78. SAUDI ARABIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 79. SAUDI ARABIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 80. REST OF LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2030, ($MILLION)
TABLE 81. REST OF LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2030, ($MILLION)
TABLE 82. ANICON: COMPANY SNAPSHOT
TABLE 83. ANICON: OPERATING SEGMENTS
TABLE 84. ANICON: PRODUCT PORTFOLIO
TABLE 85. BOEHRINGER: COMPANY SNAPSHOT
TABLE 86. BOEHRINGER: OPERATING SEGMENTS
TABLE 87. BOEHRINGER: PRODUCT PORTFOLIO
TABLE 88. CEVA : COMPANY SNAPSHOT
TABLE 89. CEVA : PRODUCT PORTFOLIO
TABLE 90. HYGIEIA: COMPANY SNAPSHOT
TABLE 91. HYGIEIA: OPERATING SEGMENTS:
TABLE 92. HYGIEIA: PRODUCT PORTFOLIO
TABLE 93. MERCK: COMPANY SNAPSHOT
TABLE 94. MERCK: OPERATING SEGMENTS
TABLE 95. MERCK: PRODUCT PORTFOLIO
TABLE 96. ROMVAC: COMPANY SNAPSHOT
TABLE 97. ROMVAC: OPERATING SEGMENTS
TABLE 98. ROMVAC: PRODUCT PORTFOLIO
TABLE 99. SANOFI: COMPANY SNAPSHOT
TABLE 100. SANOFI: OPERATING SEGMENTS
TABLE 101. SANOFI: PRODUCT PORTFOLIO
TABLE 102. VAXXINOVA: COMPANY SNAPSHOT
TABLE 103. VAXXINOVA: OPERATING SEGMENTS
TABLE 104. VAXXINOVA: PRODUCT PORTFOLIO
TABLE 105. VIRBAC: COMPANY SNAPSHOT
TABLE 106. VIRBAC: OPERATING SEGMENTS
TABLE 107. VIRBAC: PRODUCT PORTFOLIO
TABLE 108. ZOETIS: COMPANY SNAPSHOT
TABLE 109. ZOETIS: OPERATING SEGMENTS
TABLE 110. ZOETIS: PRODUCT PORTFOLIOLIST OF FIGURES
FIGURE 01. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2018-2021*)
FIGURE 02. TOP WINNING STRATEGIES: BY DEVELOPMENT (2018-2021*)
FIGURE 03. TOP WINNING STRATEGIES: BY COMPANY (2018-2021*)
FIGURE 04. TOP INVESTMENT POCKETS: ANIMAL VACCINES MARKET
FIGURE 05. TOP PLAYER POSITIONING, 2020
FIGURE 06. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTION
FIGURE 09. MODERATE THREAT OF NEW ENTRANT
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. DRIVERS, RESTRAINTS & OPPORTUNITIES
FIGURE 12. U.S. PET INDUSTRY EXPENDITURE, 2010-2019 ($BILLION)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR ATTENUATED VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR INACTIVATED VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR SUBUNIT VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR TOXOID VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR CONJUGATE VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR DNA VACCINES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. TOTAL NUMBER OF PETS OWNED IN THE U.S. (IN MILLIONS)
FIGURE 21. ANIMAL VACCINES MARKET FOR DOGS, 2020-2030 ($MILLION)
FIGURE 22. ANIMAL VACCINES MARKET FOR CATS, 2020-2030 ($MILLION)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. ANIMAL VACCINES MARKET FOR CATTLE, 2020-2030 ($MILLION)
FIGURE 25. ANIMAL VACCINES MARKET FOR PIGS, 2020-2030 ($MILLION)
FIGURE 26. ANIMAL VACCINES MARKET FOR POULTRY, 2020-2030 ($MILLION)
FIGURE 27. ANIMAL VACCINES MARKET FOR SHEEP, 2020-2030 ($MILLION)
FIGURE 28. ANIMAL VACCINES MARKET FOR HORSES, 2020-2030 ($MILLION)
FIGURE 29. ANIMAL VACCINES MARKET FOR OTHERS, 2020-2030 ($MILLION)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF AQUACULTURE ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 32. BOEHRINGER: REVENUE, 2018-2020 ($MILLION)
FIGURE 33. BOEHRINGER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. BOEHRINGER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35. MERCK: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. MERCK: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 37. MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. SANOFI: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. SANOFI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. SANOFI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. VIRBAC: REVENUE, 2018-2020 ($MILLION)
FIGURE 42. VIRBAC: REVENUE SHARE BY PRODUCT CATEGORY, 2020 (%)
FIGURE 43. VIRBAC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44. ZOETIS: NET SALES, 2018-2020 ($MILLION)
FIGURE 45. ZOETIS: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 46. ZOETIS: REVENUE SHARE BY REGION, 2020(%)

Companies Mentioned

• Merck & Co. Inc.
• Zoetis Inc.
• Ceva Sant Animale
• Sanofi S.A.
• Romvac
• Vaxxinova
• Biovac
• Merial
• Boehringer Ingelheim GmbH Anicon Labor GmbH
• Nexvet
• PHL Associates Inc.
• Hygieia Biological Laboratories
• Colorado Serum Company
• Pfizer
• Arko Laboratories Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.